We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Essity Ab (publ) | LSE:0RQC | London | Ordinary Share | SE0009922156 | ESSITY ORD SHS CLASS A |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 224.75 | 258 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Med, Dental, Hosp Eq-whsl | 173.92B | 9.55B | 13.6030 | 1.74 | 16.59B |
From Apr 2019 to Apr 2024
STOCKHOLM, April 1, 2020 /PRNewswire/ -- Hygiene and health company Essity is strengthening its offering in incontinence products through the acquisition of the Dutch company Novioscan. The company develops a wearable ultrasound technology that monitors the bladder and enables continence control. The purchase price is approximately SEK 70m (EUR 6.5m) on a debt-free basis.
The SENS-U innovation is a wearable ultrasound sensor that measures the level in the bladder. It sends a discrete notification that allows the user to empty their bladder in time. A version of SENS-U for children is already available in the market and an adult version is under development.
"The SENS-U technology is an innovative solution that will strengthen Essity's offering in incontinence care and give consumers an opportunity to live a healthier and more active life," says Ulrika Kolsrud, President Health and Medical Solutions of Essity.
Novioscan was founded in 2014 in Nijmegen, the Netherlands, and has ten employees, all of whom will remain in the company.
Essity is the leading global player in incontinence products with the TENA brand. Incontinence affects 4-8% of the world's adult population. Essity works to break barriers and the stigma associated with incontinence to improve well-being and help people live life to the fullest.
For further information, please contact:
Per Lorentz
Vice President, Corporate Communications
+46-8-788-52-51
per.lorentz@essity.com
Johan Karlsson
Vice President, Investor Relations
+46-8-788-51-30
johan.ir.karlsson@essity.com
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/essity/r/essity-acquires-smart-ultrasound-technology-for-incontinence-care,c3076795
The following files are available for download:
https://mb.cision.com/Main/15798/3076795/1221671.pdf | Essity acquires smart ultrasound technology for incontinence care |
View original content:http://www.prnewswire.com/news-releases/essity-acquires-smart-ultrasound-technology-for-incontinence-care-301033169.html
SOURCE Essity
Copyright 2020 PR Newswire
1 Year Essity Ab (publ) Chart |
1 Month Essity Ab (publ) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
